Although some studies have shown that the transforming growth factor-β1 (TGF-β1), vascular endothelial growth factor, connective tissue growth factor and interleukin (IL)-6 and IL-8 pathways are involved in the cellular behaviors of KFs [1], no effective therapeutic target for keloid treatment has been discovered. The gene discussed is TGFB1; the disease is keloid.